Newer Clinical Strategies for Combining Interferon and Cytotoxic Agents Against Solid Tumours and Hematological Malignancies
The role of interferons in the treatment of cancer continues to evolve. Despite limited single agent activity against solid tumours, interferons now appear to have an important role as modulators of the activity of a variety of cytotoxic drugs. Clinical benefits have been observed for combinations o...
Saved in:
Main Author: | Scott Wadler |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1994-01-01
|
Series: | Canadian Journal of Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/1994/474259 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Newer Hemostatic Agents Used in the Practice of Dermatologic Surgery
by: Jill Henley, et al.
Published: (2013-01-01) -
2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies
by: Michael Sandherr, et al.
Published: (2025-04-01) -
A Computational Approach towards the Development of Newer Anticancer Agents
by: Javed I. Sheikh, et al.
Published: (2010-01-01) -
Infiltrative Lung Diseases: Complications of Novel Antineoplastic Agents in Patients with Hematological Malignancies
by: Bobbak Vahid, et al.
Published: (2008-01-01) -
Oncolytic Virotherapy for Hematological Malignancies
by: Swarna Bais, et al.
Published: (2012-01-01)